Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Lactobacillus Plantarum (LBP, IND# 17339) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)

NCT03057054 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT03057054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03057054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Lactobacillus Plantarum (LBP, IND# 17339) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 30, 2018
Completion date
June 30, 2026
Enrollment
173 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft versus host disease, hematopoietic and lymphatic system neoplasm, leukemia, lymphoma